Biotricity Insiders
Biotricity employs about 55 people. The company is managed by 8 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 6.88 employees per reported executive. Break down of Biotricity's management performance can provide insight into the company performance.
Waqaas AlSiddiq Chairman Founder, Chairman, CEO and Executive Officer |
Biotricity |
Biotricity Management Team Effectiveness
The company has return on total asset (ROA) of (0.8862) % which means that it has lost $0.8862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.Biotricity Workforce Comparison
Biotricity is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,275. Biotricity claims roughly 55.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.96. Biotricity Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biotricity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biotricity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biotricity insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
John Ayanoglou over three months ago Acquisition by John Ayanoglou of 50000 shares of Biotricity at 0.73 subject to Rule 16b-3 | ||
David Rosa over a year ago Acquisition by David Rosa of 75930 shares of Biotricity subject to Rule 16b-3 | ||
Waqaas AlSiddiq over a year ago Acquisition by Waqaas AlSiddiq of 350000 shares of Biotricity subject to Rule 16b-3 | ||
John Ayanoglou over a year ago Acquisition by John Ayanoglou of 50000 shares of Biotricity subject to Rule 16b-3 |
Biotricity Notable Stakeholders
A Biotricity stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biotricity often face trade-offs trying to please all of them. Biotricity's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biotricity's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Waqaas AlSiddiq | Founder, Chairman, CEO and Executive Officer | Profile | |
George Nikopoulos | Director Development | Profile | |
Fareeha Siddiqui | Senior Solutions | Profile | |
Amjad Talpur | Senior Operations | Profile | |
Amir Ali | Chief Officer | Profile | |
John Ayanoglou | Chief Officer | Profile | |
Andy Wong | Vice Operations | Profile | |
Matt Zabel | Vice Strategy | Profile |
About Biotricity Management Performance
The success or failure of an entity such as Biotricity often depends on how effective the management is. Biotricity management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotricity management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotricity management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.
Please note, the imprecision that can be found in Biotricity's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotricity. Check Biotricity's Beneish M Score to see the likelihood of Biotricity's management manipulating its earnings.
Biotricity Workforce Analysis
Traditionally, organizations such as Biotricity use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biotricity within its industry.Biotricity Manpower Efficiency
Return on Biotricity Manpower
Revenue Per Employee | 219.3K | |
Revenue Per Executive | 1.5M | |
Net Loss Per Employee | 256.3K | |
Net Loss Per Executive | 1.8M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Biotricity Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |